Differences in mGluR5 Availability Depending on the Level of Social Avoidance in Drug-Naïve Young Patients with Major Depressive Disorder.
Jeong Hee KimYo-Han JooYoung-Don SonHang-Keun KimJong-Hoon KimPublished in: Neuropsychiatric disease and treatment (2022)
Our exploratory study shows significant differences in frontal mGluR5 availability depending on the level of social avoidance in drug-naïve non-smoking MDD patients, suggesting that social avoidance should be considered as one of the clinical factors involved in mGluR5 signaling changes in depression.
Keyphrases